A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.
By C. Cutler, Stephanie J. Lee, P. Greenberg, H. Deeg, W. Pérez, C. Anasetti, B. Bolwell, M. Cairo, R. Gale, John P. Klein and 11 more. Blood, 2004
671 citations recorded by the source corpus.
Subfields: Hematology
View Paper: https://www.semanticscholar.org/paper/a0fe9ca8901bb390d5abfa3be41938a81e14bead
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- L. Malcovati
- E. Hellström-Lindberg
- D. Bowen
- L. Adès
- A. Kuendgen
- J. Čermák
- G. Sanz
- P. Fenaux
Citations in the corpus
- Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. (2007, background): “As compared with the four groups defined by the IPSS, WPSS was able to identify five risk groups of MDS patients with different survival and risk of AML.”
- Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. (2013, methodology): “A clinical decision analysis from the International Bone Marrow Transplant Registry (IBMTR) examining 3 strategies for patients with newly diagnosed MDS and deemed suitable for myeloablative allogeneic SCT from HLA-identical sibling donors (transplantation at diagnosis, transplantation at leukemic p”